Compare Stocks: AVTX, RLAY, LEGN, and TNGX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVTX Avalo Therapeutics	$19.23 +1.2%	$19.12	$9.54 ▼ $24.27	$1.02B	0.78	744,811 shs	633,218 shs
LEGN Legend Biotech	$21.52 -1.1%	$22.72	$16.24 ▼ $37.50	$4.21B	0.4	2.08 million shs	811,970 shs
RLAY Relay Therapeutics	$19.04 +0.2%	$19.36	$3.86 ▼ $21.27	$4.17B	1.69	2.38 million shs	2.05 million shs
TNGX Tango Therapeutics	$22.52 -1.1%	$27.05	$6.25 ▼ $34.39	$3.84B	1.12	2.16 million shs	1.46 million shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVTX Avalo Therapeutics	+1.21%	-1.84%	+2.07%	+46.79%	+82.10%
LEGN Legend Biotech	-1.06%	+8.25%	+12.97%	-34.03%	-40.14%
RLAY Relay Therapeutics	+0.16%	+1.44%	-3.30%	+40.83%	+363.26%
TNGX Tango Therapeutics	-1.05%	-3.51%	-21.78%	+11.37%	+236.12%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVTX Avalo Therapeutics	$19.23 +1.2%	$19.12	$9.54 ▼ $24.27	$1.02B	0.78	744,811 shs	633,218 shs
LEGN Legend Biotech	$21.52 -1.1%	$22.72	$16.24 ▼ $37.50	$4.21B	0.4	2.08 million shs	811,970 shs
RLAY Relay Therapeutics	$19.04 +0.2%	$19.36	$3.86 ▼ $21.27	$4.17B	1.69	2.38 million shs	2.05 million shs
TNGX Tango Therapeutics	$22.52 -1.1%	$27.05	$6.25 ▼ $34.39	$3.84B	1.12	2.16 million shs	1.46 million shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVTX Avalo Therapeutics	+1.21%	-1.84%	+2.07%	+46.79%	+82.10%
LEGN Legend Biotech	-1.06%	+8.25%	+12.97%	-34.03%	-40.14%
RLAY Relay Therapeutics	+0.16%	+1.44%	-3.30%	+40.83%	+363.26%
TNGX Tango Therapeutics	-1.05%	-3.51%	-21.78%	+11.37%	+236.12%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVTX Avalo Therapeutics	2.85	Moderate Buy	$45.10	134.53% Upside
LEGN Legend Biotech	2.47	Hold	$53.43	148.27% Upside
RLAY Relay Therapeutics	2.93	Moderate Buy	$25.92	36.12% Upside
TNGX Tango Therapeutics	2.75	Moderate Buy	$43.46	92.99% Upside

Current Analyst Ratings Breakdown

Latest AVTX, RLAY, LEGN, and TNGX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/4/2026	LEGN Legend Biotech	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$65.00
9/4/2026	LEGN Legend Biotech	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$65.00
9/1/2026	LEGN Legend Biotech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/20/2026	RLAY Relay Therapeutics	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/20/2026	RLAY Relay Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$28.00 ➝ $29.00
8/18/2026	LEGN Legend Biotech	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/18/2026	TNGX Tango Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$66.00 ➝ $68.00
8/14/2026	RLAY Relay Therapeutics	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$28.00 ➝ $31.00
8/12/2026	LEGN Legend Biotech	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$48.00 ➝ $49.00
8/12/2026	TNGX Tango Therapeutics	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$32.00 ➝ $35.00
8/12/2026	LEGN Legend Biotech	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform	$75.00 ➝ $40.00

(Data available from 9/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVTX Avalo Therapeutics	$60K	17,188.42	N/A	N/A	$8.37 per share	2.30
LEGN Legend Biotech	$1.03B	4.05	N/A	N/A	$6.35 per share	3.39
RLAY Relay Therapeutics	$10.35M	403.14	N/A	N/A	$4.06 per share	4.69
TNGX Tango Therapeutics	$62.38M	60.87	N/A	N/A	$6.08 per share	3.70

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVTX Avalo Therapeutics	-$78.26M	-$4.37	N/A	N/A	N/A	N/A	-58.03%	-48.22%	11/5/2026 (Estimated)
LEGN Legend Biotech	-$296.80M	-$0.25	N/A	18.39	N/A	-7.21%	-8.71%	-5.40%	11/11/2026 (Estimated)
RLAY Relay Therapeutics	-$276.48M	-$1.57	N/A	N/A	N/A	N/A	-42.27%	-38.67%	11/5/2026 (Estimated)
TNGX Tango Therapeutics	-$101.59M	-$0.85	N/A	N/A	N/A	N/A	-25.75%	-23.36%	11/3/2026 (Estimated)

Latest AVTX, RLAY, LEGN, and TNGX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/11/2026	Q2 2026	LEGN Legend Biotech	$0.07	$0.09	+$0.02	$0.18	$355.96 million	$387.50 million
8/11/2026	Q2 2026	TNGX Tango Therapeutics	-$0.3172	-$0.37	-$0.0528	-$0.37	$1.56 million	N/A
8/6/2026	Q2 2026	AVTX Avalo Therapeutics	-$0.5827	-$0.83	-$0.2473	-$0.83	N/A	N/A
8/6/2026	Q2 2026	RLAY Relay Therapeutics	-$0.3911	-$0.41	-$0.0189	-$0.41	$0.96 million	$0.35 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVTX Avalo Therapeutics	N/A	N/A	N/A	N/A	N/A
LEGN Legend Biotech	N/A	N/A	N/A	N/A	N/A
RLAY Relay Therapeutics	N/A	N/A	N/A	N/A	N/A
TNGX Tango Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVTX Avalo Therapeutics	N/A	19.31	19.31
LEGN Legend Biotech	N/A	3.04	2.94
RLAY Relay Therapeutics	N/A	18.27	18.27
TNGX Tango Therapeutics	N/A	50.82	50.82

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVTX Avalo Therapeutics	87.06%
LEGN Legend Biotech	70.89%
RLAY Relay Therapeutics	96.98%
TNGX Tango Therapeutics	78.99%

Insider Ownership

Company	Insider Ownership
AVTX Avalo Therapeutics	4.46%
LEGN Legend Biotech	0.02%
RLAY Relay Therapeutics	5.04%
TNGX Tango Therapeutics	6.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVTX Avalo Therapeutics	40	53.63 million	51.24 million	Not Optionable
LEGN Legend Biotech	2,965	193.77 million	193.73 million	Optionable
RLAY Relay Therapeutics	330	219.14 million	208.10 million	Optionable
TNGX Tango Therapeutics	90	168.61 million	157.65 million	Optionable

AVTX, RLAY, LEGN, and TNGX Headlines

Recent News About These Companies

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 3 at 4:05 PM | globenewswire.com

390,920 Shares in Tango Therapeutics, Inc. $TNGX Acquired by Bank of New York Mellon Corp

September 2 at 3:28 AM | marketbeat.com

Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Average Recommendation of "Moderate Buy" by Brokerages

September 2 at 1:45 AM | americanbankingnews.com

Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

September 1, 2026 | globenewswire.com

181,212 Shares in Tango Therapeutics, Inc. $TNGX Purchased by The Manufacturers Life Insurance Company

September 1, 2026 | marketbeat.com

Alyeska Investment Group L.P. Increases Holdings in Tango Therapeutics, Inc. $TNGX

September 1, 2026 | marketbeat.com

Nantahala Capital Management LLC Takes Position in Tango Therapeutics, Inc. $TNGX

August 29, 2026 | marketbeat.com

Jefferies Financial Group Inc. Makes New Investment in Tango Therapeutics, Inc. $TNGX

August 28, 2026 | marketbeat.com

Oxford Nanopore Technologies (OTCMKTS:ONTTF) vs. Tango Therapeutics (NASDAQ:TNGX) Head to Head Contrast

August 28, 2026 | americanbankingnews.com

Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Rating of "Moderate Buy" by Brokerages

August 28, 2026 | marketbeat.com

Seven Fleet Capital Management LP Raises Stock Position in Tango Therapeutics, Inc. $TNGX

August 27, 2026 | marketbeat.com

Jupiter Topco LLC Invests $157.99 Million in Tango Therapeutics, Inc. $TNGX

August 27, 2026 | marketbeat.com

Boone Capital Management LLC Invests $14.24 Million in Tango Therapeutics, Inc. $TNGX

August 27, 2026 | marketbeat.com

Algert Global LLC Grows Position in Tango Therapeutics, Inc. $TNGX

August 27, 2026 | marketbeat.com

Tango Therapeutics (NASDAQ:TNGX) Trading Up 4.8% - Here's Why